Rui Zhu
16Patents
3h-index
24Co-inventors
52Inventor score
Filing activity: Aug 4, 2017 → Dec 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10450565B2 | Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use | Physics | 7 | Active |
| US10780108B2 | RNAi agents for Hepatitis B virus infection | Emerging Cross-Sectional Technologies | 4 | Active |
| US10597657B2 | RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3) | Chemistry; Metallurgy | 3 | Active |
| US11203756B2 | Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use | Physics | 2 | Active |
| US11214801B2 | RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3) | Chemistry; Metallurgy | 1 | Active |
| US10590416B2 | RNAi agents for inhibiting expression of alpha-ENaC and methods of use | Chemistry; Metallurgy | 1 | Active |
| US11517584B2 | RNAi agents for Hepatitis B virus infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US11214802B2 | RNAi agents for inhibiting expression of alpha-ENaC and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12365899B2 | RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3) | Chemistry; Metallurgy | 0 | Active |
| US11590156B2 | RNAi agents for hepatitis B virus infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US11884920B2 | Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use | Physics | 0 | Active |
| US12221610B2 | RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions thereof, and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11492624B2 | RNAi agents and compositions for inhibiting expression of Asialoglycoprotein receptor 1 | Chemistry; Metallurgy | 0 | Active |
| US11597701B2 | Integrin ligands and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12042509B2 | Prekallikrein-modulating compositions and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10995335B2 | RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.